Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
  • A61K8/35—Ketones, e.g. benzophenone
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
  • A61K8/42—Amides
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
  • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
  • A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
  • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
  • A61K8/4966—Triazines or their condensed derivatives
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/60—Sugars; Derivatives thereof
  • A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
  • A61P17/16—Emollients or protectives, e.g. against radiation
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
  • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
  • A61K2800/52—Stabilizers

Definitions

• the present invention relates to improving the stability of at least one UV-photoprotecting dibenzoylmethane compound with respect to UV-radiation, by formulating such dibenzoylmethane compound with an effective UV-photostabilizing amount of at least one insoluble organic UV-screening agent in the micronized form or state, the mean size of the particles of which ranging from 0.01 to 2 ⁇ m.
• the present invention also relates to formulating an insoluble organic UV-screening agent in the micronized form, the mean size of the particles of which ranging from 0.01 to 2 ⁇ m, into cosmetic/dermatological compositions comprising at least one UV-photoprotecting dibenzoylmethane compound, wherein the photostability of said at least one dibenzoylmethane compound with respect to UV radiation is conspicuously enhanced.
• UV-A radiation of wavelengths of from 320 nm to 400 nm, which promotes tanning of the skin, also is capable of causing damage thereto, in particular in the case of a sensitive skin or of a skin continually exposed to solar radiation.
• UV-A radiation causes, in particular, loss of elasticity of the skin and the appearance of wrinkles which promotes premature skin aging.
• UV-A radiation promotes the onset of the erythema reaction or amplifies this reaction in certain individuals and may even be responsible for phototoxic or photoallergic reactions.
• an increasing number of individuals seek to control the effect of UV-A radiation on their skin. It is therefore desirable to also screen out UV-A radiation.
• a particularly advantageous class of UV-A screening agents is that of the dibenzoylmethane compounds, and in particular 4-(tert-butyl)-4′-methoxydibenzoylmethane; this is because these derivatives or compounds exhibit a high intrinsic absorption power.
• dibenzoylmethane compounds which are now well known per se as screening agents active in the UV-A range, are described, in particular, in FR-A-2,326,405 and FR-A-2,440,933 and in EP-A-0,114,607. Too, 4-(tert-butyl)-4′-methoxydibenzoylmethane is currently commercially available under the trademark “Parsol 1789” by Hoffmann Laroche.
• the dibenzoylmethane derivatives are compounds which are relatively sensitive to ultraviolet radiation (in particular UV-A radiation), namely, more specifically, they have an unfortunate tendency to decompose more or less rapidly under the effect or influence of UV-A radiation.
• UV-A radiation ultraviolet-A radiation
• this substantial lack of photochemical stability of dibenzoylmethane compounds under the influence of ultraviolet radiation, to which they are naturally intended to be subjected or exposed, does not permit a guarantee of constant protection during prolonged exposure to the sun, such that repeated applications at regular and frequent intervals of time are necessary in order to provide the user with effective protection of the skin against UV rays.
• the present invention features the stabilization of dibenzoylmethane compounds with respect of UV radiation (wavelengths ranging from 280 nm to 400 nm, approximately), in particular solar radiation, by formulating said dibenzoylmethane compounds with an effective UV-photostabilizing amount of at least one insoluble organic UV screening agent in the micronized form.
• insoluble organic UV-screening agent organic UV-screening agents having a solubility in water at 25° C. of less than 0.1% by weight and a solubility in liquid paraffin at 25° C. of less than 1% by weight.
• an effective UV-photostabilizing amount of insoluble organic UV-screening agent is intended an amount sufficient to provide a notable and significant improvement in the UV-photostability of the dibenzoylmethane compound(s) comprising UV-photoprotective cosmetic compositions.
• This minimum amount of UV-photostabilizing agent to be formulated which can vary depending on the nature of the cosmetically acceptable vehicle, diluent or carrier included in the composition, can be determined without any difficulty via a conventional test for the measurement of photostability, such as that given in the examples below.
• This invention thus also features formulating an insoluble organic UV-screening agent into a cosmetic/dermatological composition comprising at least one dibenzoylmethane compound for the purpose of improving the stability with respect to UV-radiation of any such dibenzoylmethane compound present.
• the insoluble organic screening agents according to the invention are provided in micronized form.
• the mean or average size of the particles ranges from 0.01 ⁇ m to 2 ⁇ m and more preferably from 0.02 ⁇ m to 1.5 ⁇ m and even more preferably from 0.03 ⁇ m to 1.0 ⁇ m.
• the insoluble organic screening agents according to the invention may be provided in the desired particulate form by any appropriate means such as, in particular, grinding in the dry state or in solvent medium, sieving, spray-drying, micronization or spraying.
• the insoluble organic screening agents according to the invention in micronized form may, in particular, be provided by a method of grinding an insoluble UV-screening agent in the form of particles having a coarse size in the presence of an appropriate surfactant which makes it possible to enhance the dispersion of the particles thus obtained in the cosmetic formulations.
• the grinding apparatus may be a jet mill, a ball mill, a vibratory mill or a hammer mill and preferably a mill featuring high-speed agitation or an impact mill and more particularly a rotating ball mill, a vibratory mill, a tube mill or a rod mill.
• the alkyl polyglucosides having the structure C n H 2n ⁇ 1 O(C 6 H 10 O 5 ) x H in which n is an integer from 8 to 16 and x is the average degree of polymerization of the structural unit (C 6 H 10 O 5 ) and ranges from 1.4 to 1.6, are included as surfactants for the grinding of the screening agents.
• C 1 -C 12 esters of a compound having the structure C n H 2n+1 O(C 6 H 10 O 5 ) x H and more precisely an ester prepared by reacting a C 1 -C 12 carboxylic acid such as formic, acetic, propionic, butyric, sulfosuccinic, citric or tartaric acid with one or more free OH functions on the glucoside unit (C 6 H 10 O 5 ).
• Such surfactants are typically employed at a concentration ranging from 1% to 50% by weight and more preferably from 5% to 40% by weight relative to the insoluble screening agent in its micronized form.
• dibenzoylmethane compounds sought to be photostabilized according to the present invention are already well known per se and described, in particular, in FR-A-2,326,405, FR-A-2,440,933 and EP-A-0,114,607 (hereby expressly incorporated by reference).
• dibenzoylmethane derivatives include:
• UV-screening agent has the following structural formula:
• Another dibenzoylmethane compound which is preferred according to this invention is 4-isopropyldibenzoylmethane, a UV-screening agent marketed under the trademark “Eusolex 8020” by Merck. It has the following structural formula:
• the dibenzoylmethane derivative or derivatives can be present in the compositions in accordance with the invention, or in the compositions intended to be stabilized in accordance herewith, at concentrations ranging from 0.01% to 10% by weight and preferably ranging from 0.1% to 6% by weight with respect to the total weight of the composition.
• the insoluble organic UV-screening agents in accordance with this invention may be selected, in particular, from among the organic UV-screening agents of the oxanilide type, of the triazine type, of the triazole type, of the vinylamide type and of the cinnamide type.
• UV-screening agents of the oxanilide type include those having the structural formula (1):
• T 1 , T′ 1 , T 2 and T′ 2 which may be identical or different, are each a C 1 -C 8 alkyl radical or a C 1 -C 8 alkoxy radical. These compounds are described in WO-95/22,959.
• TINUVIN 315 and TINUVIN 312 marketed by Ciba-Geigy and respectively having the structural formulae:
• insoluble UV-screening agents of the triazine type in accordance with the invention are the insoluble derivatives of s-triazine substituted by benzalmalonate and/or phenylcyanoacrylate groups, such as those described in EP-A-0,790,243 (also expressly incorporated by reference).
• UV-screening agents of the triazine type the following compounds are more particularly exemplary:
• insoluble UV-screening agents of the triazine type in accordance with the invention are those having the following structural formula (2):
• R 1 , R 2 , R 3 are independently phenyl, phenoxy, pyrrolo, in which the phenyl, phenoxy and pyrrolo radicals are optionally substituted with one, two or three substituents selected from among OH, C 1 -C 18 alkyl or alkoxy, C 1 -C 18 carboxyalkyl, C 5 -C 8 cycloalkyl, a methylidenecamphor group, a group —(CH ⁇ CH) n (CO)—OR 4 , wherein R 4 is either C 1 -C 18 alkyl or cinnamyl, and n is equal to 0or 1.
• insoluble UV-screening agents of the triazine type in accordance with the invention, exemplary are the insoluble derivatives of s-triazine substituted by benzotriazole and/or benzothiazole groups, such as those described in WO-98/25,922 (also expressly incorporated by reference).
• Exemplary organic UV-screening agents of the triazole type in accordance with the invention are those of the following structural formula (3) as described in WO-95/22,959 (also expressly incorporated by reference):
• T 9 is a hydrogen atom or a C 1 -C 18 alkyl radical
• T 10 and T 11 which may be identical or different, are each a C 1 -C 18 alkyl radical which is optionally substituted with a phenyl radical.
• Exemplary compounds of formula (7) are the commercial products TINUVIN 328, 320, 234 and 350 marketed by Ciba-Geigy having the following structural formulae:
• Exemplary organic UV-screening agents of the triazole type in accordance with the invention are the compounds described in U.S. Pat. Nos. 5,687,521, 5,687,521, 5,373,037, 5,362,881 and, in particular, [2,4′-dihydroxy-3-(2H-benzotriazol-2-yl)-5-(1,1,3,3-tetramethylbutyl)-2′-n-octoxy-5′-benzoyl]diphenylmethane marketed under the trademark MIXXIM PB30 by Fairmount Chemical and having the structural formula:
• exemplary organic UV-screening agents of the benzotriazole type in accordance with the invention are the methylenebis(hydroxyphenyl-benzotriazole) compounds having the following structural formula:
• radicals T 12 and T 13 which may be identical or different, are each a C 1 -C 18 alkyl radical which may be substituted with one or more radicals selected from among a C 1 -C 4 alkyl, a C 5 -C 12 cycloalkyl, or an aryl radical.
• These compounds are per se known and are described in U.S. Pat. Nos. 5,237,071 and 5,166,355, GB-A-2,303,549, DE-197,26,184 and EP-A-893,119 (also expressly incorporated by reference).
• the C 1 -C 18 alkyl radicals may be linear or branched and include, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, tert-octyl, n-amyl, n-hexyl, n-heptyl, n-octyl, iso-octyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, tetradecyl, hexyldecyl or octadecyl; the C 5 -C 12 cycloalkyl radicals include, for example, cyclopentyl, cyclohexyl, cyclooctyl; and the aryl radicals include, for example, phenyl or benzyl.
• the compound (a) with the nomenclature 2,2′-methylenebis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol] is marketed under the trademark MIXXIM BB/100 by Fairmount Chemical. It is marketed in micronized form under the trademark TINOSORB M by Ciba-Geigy.
• organic screening agents of the vinylamide type in accordance with the invention, exemplary are the compounds of the following formulae which are described in WO-95/22,959 (expressly incorporated by reference):
• T 14 is a C 1 -C 18 , preferably C 1 -C 5 , alkyl radical or a phenyl group which is optionally substituted with one, two or three radicals selected from among OH, C 1 -C 18 alkyl, C 1 -C 8 alkoxy, or a radical —C( ⁇ O)—OT 19 wherein T 19 is a C 1 -C 18 alkyl radical;
• T 15 , T 16 , T 17 and T 18 which may be identical or different, are each a C 1 -C 18 , preferably C 1 -C 5 , alkyl radical or a hydrogen atom;
• Y is N or O and r is equal to 0 or 1.
• Exemplary insoluble organic screening agents of the cinnamamide type are those compounds described in WO-95/22,959 (expressly incorporated by reference) and having the following structural formula:
• T 20 is a hydroxyl or C 1 -C 4 alkoxy, preferably methoxy or ethoxy, radical
• T 21 is hydrogen, C 1 -C 4 alkyl, preferably methyl or ethyl
• T 22 is a radical —(CONH)s-phenyl wherein s is equal to 0 or 1 and the phenyl group may be substituted with one, two or three groups selected from among OH, C 1 -C 18 alkyl, C 1 -C 8 alkoxy, or a radical —C( ⁇ O)—OT 23 wherein T 23 is a C 1 -C 18 alkyl and more preferably T 23 is a phenyl, 4-methoxyphenyl or phenylaminocarbonyl group.
• cinnamamide dimers such as those described in U.S. Pat. No. 5,888,481, for example, the compound having the structural formula:
• insoluble organic UV-screening agents are the polyvalent metal salts (for example Ca 2+ , Zn 2+ , Mg 2+ , Ba 2 +, Al 3+ or Zr 4+ ) of sulfonic or carboxylic organic screening agents such as the polyvalent metal salts of sulfonated derivatives of benzylidenecamphor, for example those described in FR-A-2,639,347; the polyvalent metal salts of sulfonated derivatives of benzimidazole, for example those described in EP-A-893,119; and the polyvalent metal salts of cinnamic acid derivatives, for example those described in JP-87/166,517.
• polyvalent metal salts for example Ca 2+ , Zn 2+ , Mg 2+ , Ba 2 +, Al 3+ or Zr 4+
• sulfonic or carboxylic organic screening agents such as the polyvalent metal salts of sulfonated derivatives of benzylidenecamphor,
• micronized insoluble organic screening agent(s) according to the invention are generally present in the screening compositions according to the invention at a total concentration ranging from 0.1% and 15% by weight approximately, and preferably from 0.2% and 10% by weight approximately, relative to the total weight of the composition.
• This invention also features cosmetic or dermatological compositions comprising at least one emulsion of the subject compounds.
• the anti-sun cosmetic compositions according to the invention may of course contain one or more additional organic screening agents which are active in UV-A and/or UV-B ranges (absorbers), which are soluble in at least one of the phases of the subject compositions.
• additional screening agents may be selected, in particular, from among the cinnamic derivatives; the dibenzoylmethane derivatives; the salicylic derivatives, the camphor derivatives; the triazine derivatives such as those described in U.S. Pat. No.
• Exemplary such additional sunscreening agents active in the UV-A and/or UV-B ranges, which are soluble in at least one of the phases of the subject compositions, include:
• polyorganosiloxanes containing a benzotriazole function such as Drometrizole Trisiloxane.
• compositions according to the invention may also contain agents for tanning and/or for artificial tanning of the skin (self-tanning agents), such as, for example, dihydroxyacetone (DHA).
• self-tanning agents such as, for example, dihydroxyacetone (DHA).
• DHA dihydroxyacetone
• the cosmetic compositions according to the invention may also contain pigments or, alternatively, nanopigments (mean size of the primary particles: generally ranging from 5 nm to 100 nm, preferably from 10 nm to 50 nm) of metal oxides, coated or uncoated, such as, for example, nanopigments of titanium dioxide (amorphous or crystallized in the rutile and/or anatase state), of iron oxide, zinc oxide, zirconium oxide or cerium oxide, which are all UV photoprotective agents well known per se. Conventional coating agents are moreover alumina and/or aluminum stearate.
• nanopigments of metal oxides, coated or uncoated are, in particular, described in EP-A-0,518,772 and EP-A-0,518,773.
• compositions of the invention may comprise, in addition, conventional cosmetic additives and adjuvants selected, in particular, from among fatty substances, organic solvents, thickeners, demulcents, opacifiers, colorants, stabilizers, emollients, antifoaming agents, moisturizing agents, perfumes, preservatives, polymers, fillers, sequestrants, propellants, alkalinizing or acidifying agents or any other ingredient customarily formulated into cosmetics, in particular for the production of anti-sun/sunscreen compositions in the form of emulsions.
• conventional cosmetic additives and adjuvants selected, in particular, from among fatty substances, organic solvents, thickeners, demulcents, opacifiers, colorants, stabilizers, emollients, antifoaming agents, moisturizing agents, perfumes, preservatives, polymers, fillers, sequestrants, propellants, alkalinizing or acidifying agents or any other ingredient customarily formulated into
• the fatty substances may be an oil or a wax or mixtures thereof, and they also comprise fatty acids, fatty alcohols and esters of fatty acids.
• the oils may be selected from among animal, vegetable, mineral or synthetic oils and, in particular, from among liquid paraffin, paraffin oil, silicone oils, volatile or otherwise, isoparaffins, polyolefins, fluorinated or perfluorinated oils.
• the waxes may be animal, fossil, vegetable, mineral or synthetic waxes which are also known per se.
• Exemplary organic solvents include the lower alcohols and polyols.
• compositions of the invention may be formulated according to techniques well known to this art, in particular those suited for the preparation of emulsions of the oil-in-water or water-in-oil type.
• compositions may be provided, in particular, in the form of a simple or complex (O/W, W/O, O/W/O or W/O/W) emulsion such as a cream, a milk, a gel or a gel cream, of a powder, a lotion, an ointment, a solid stick and may optionally be packaged as an aerosol and provided in the form of a foam, mousse or spray.
• a simple or complex (O/W, W/O, O/W/O or W/O/W) emulsion such as a cream, a milk, a gel or a gel cream, of a powder, a lotion, an ointment, a solid stick and may optionally be packaged as an aerosol and provided in the form of a foam, mousse or spray.
• the aqueous phase thereof may comprise a nonionic vesicular dispersion prepared according to known techniques (Bangham, Standish and Watkins, J. Mol. Biol, 13, 238 (1965), FR-2,315,991 and FR-2,416,008).
• the cosmetic compositions according to the invention may be formulated for protecting the human epidermis or the hair against the damaging effects of ultraviolet radiation, as an anti-sun composition or as a makeup product.
• the cosmetic compositions according to the invention are formulated for protecting the human epidermis against UV rays, or as anti-sun/sunscreen compositions, same may be provided in the form of a suspension or a dispersion in solvents or fatty substances, in the form of a nonionic vesicular dispersion or, alternatively, in the form of an emulsion, preferably of the oil-in-water type, such as a cream or a milk, in the form of an ointment, a gel, a gel cream, a solid stick, a powder, a stick, an aerosol foam or a spray.
• a suspension or a dispersion in solvents or fatty substances in the form of a nonionic vesicular dispersion or, alternatively, in the form of an emulsion, preferably of the oil-in-water type, such as a cream or a milk, in the form of an ointment, a gel, a gel cream, a solid stick,
• the cosmetic compositions according to the invention are formulated for protecting the hair against UV rays, same may be provided in the form of a shampoo, a lotion, a gel, an emulsion, a nonionic vesicular dispersion and may constitute, for example, a rinse-off composition to be applied before or after shampooing, before or after dyeing or bleaching, before, during or after permanent-waving or hair straightening, a hair-styling or treatment lotion or gel, a lotion or gel for blow drying or hair setting, a composition for permanent waving or straightening, dyeing or bleaching the hair.
• a rinse-off composition to be applied before or after shampooing, before or after dyeing or bleaching, before, during or after permanent-waving or hair straightening, a hair-styling or treatment lotion or gel, a lotion or gel for blow drying or hair setting, a composition for permanent waving or straightening, dyeing or bleaching the hair.
• compositions are formulated as makeup products for the eyelashes, the eyebrows or the skin, such as a treatment cream for the epidermis, foundation, lipstick, eyeshadow, blusher, mascara or eyeliner, same may be provided in a solid or pasty, anhydrous or aqueous form, such as oil-in-water or water-in-oil emulsions, nonionic vesicular dispersions or alternatively suspensions.
• the aqueous phase (comprising in particular the hydrophilic screening agents), generally constitutes from 50% to 95% by weight, preferably from 70% to 90% by weight, relative to the total weight of the formulation, the oily phase (comprising in particular the lipophilic screening agents), from 5% to 50% by weight, preferably from 10% to 30% by weight, relative to the total weight of the formulation, and the (co)emulsifier(s) from 0.5% to 20% by weight, preferably from 2% to 10% by weight, also relative to the total weight of the formulation.
• the present invention thus features formulating the subject emulsions for the production of cosmetic compositions for protecting the skin and/or the hair against ultraviolet radiation, in particular solar radiation.
• test samples and 3 control samples were prepared for each formula. 2 mg/cm 2 of formula were deposited with a spatula on poly(methyl methacrylate) plaques.
• the test plaques were exposed for 1 h, 39 min, to a Suntest Heraeus equipped with a Xenon lamp having, as UV-A flux, 3.02 ⁇ 10 ⁇ 3 W/cm 2 and, as UV-B flux, 2.05 ⁇ 10 ⁇ 4 W/cm 2 , and the control plaques were stored for the same time and at the same temperature (35°-40°C.) in darkness.
• the screening agents were extracted by immersing each plaque in 50 g of tetrahydrofuran and by subjecting them to ultrasound for 15 min in order to ensure good extraction.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Birds (AREA)
• Epidemiology (AREA)
• Dermatology (AREA)
• Emergency Medicine (AREA)
• General Chemical & Material Sciences (AREA)
• Toxicology (AREA)
• Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Engineering & Computer Science (AREA)
• Medicinal Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Organic Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Cosmetics (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Medicinal Preparation (AREA)
• Hybrid Cells (AREA)
• Solid-Sorbent Or Filter-Aiding Compositions (AREA)
• Fats And Perfumes (AREA)
• Photovoltaic Devices (AREA)
• Inorganic Compounds Of Heavy Metals (AREA)
• Optical Filters (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=9551252

Family Applications (1)

Country Status (13)

Cited By (2)

Families Citing this family (8)

Citations (5)

• 1999
  • 1999-10-22 FR FR9913222A patent/FR2799966B1/fr not_active Expired - Fee Related
• 2000
  • 2000-10-11 DE DE60000075T patent/DE60000075T2/de not_active Revoked
  • 2000-10-11 PT PT00402809T patent/PT1093797E/pt unknown
  • 2000-10-11 EP EP00402809A patent/EP1093797B1/fr not_active Revoked
  • 2000-10-11 DK DK00402809T patent/DK1093797T3/da active
  • 2000-10-11 AT AT00402809T patent/ATE213403T1/de not_active IP Right Cessation
  • 2000-10-11 ES ES00402809T patent/ES2173072T3/es not_active Expired - Lifetime
  • 2000-10-20 CA CA002324047A patent/CA2324047A1/fr not_active Abandoned
  • 2000-10-20 AU AU66642/00A patent/AU740339B2/en not_active Ceased
  • 2000-10-23 KR KR20000062370A patent/KR100385596B1/ko not_active IP Right Cessation
  • 2000-10-23 BR BR0006736-9A patent/BR0006736A/pt not_active Application Discontinuation
  • 2000-10-23 JP JP2000361939A patent/JP3607864B2/ja not_active Expired - Fee Related
  • 2000-10-23 US US09/693,887 patent/US6419908B1/en not_active Expired - Fee Related

Patent Citations (6)

Also Published As

Similar Documents

Legal Events